| |
|
|
|
|
|
|
Serenex’s current investors focus significantly or exclusively in life science and biotechnology portfolio companies. Our investors include: 
| | Mediphase Venture Partners | | Newton, Massachusetts | | www.mediphaseventure.com | | | 
| | Lilly Ventures | | Indianapolis, Indiana | | www.lillyventures.com | 
| | Intersouth Partners | | Durham, North Carolina | | | 
| | Seaflower Ventures | | Waltham, Massachusetts |  | | | Western Technology Investment | | San Jose, California | | www.westerntech.com | | |  | | Takeda Research Investment | | Palo Alto, California | | www.tri-takeda.com |  | | | Ritchie Capital Management, LLC. | | Lisle, IL | | | www.ritchiecapital.com | | |  | | Pac-Link Bio Venture Capital Investment Corporation | | Palo Alto, CA | | PacLinkVenture |  | | | MC Life Science Ventures | | | New York, NY | | | Mistubishi International | | |  | | Pearl Street Venture Funds, L.P. | | Indianapolis, IN | | Pearl Street Venture Funds |  | | Yorkville Advisors, LLC | | | Jersey City, NJ | | | Yorkville Advisors, LLC | | | |
|
|
 |
|